| | |
Per Share
|
| |
Per Pre-Funded
Warrant |
| |
Total
|
| |||||||||
Public offering price
|
| | | $ | 4.750 | | | | | $ | 4.749 | | | | | $ | 59,997,899.70 | | |
承保折扣和佣金(1)
|
| | | $ | 0.285 | | | | | $ | 0.285 | | | | | $ | 3,600,000.30 | | |
未扣除費用的Marinus PharmPharmticals,Inc.收益
|
| | | $ | 4.465 | | | | | $ | 4.464 | | | | | $ | 56,397,899.40 | | |
|
關於本招股説明書副刊
|
| | | | S-i | | |
|
招股説明書補充摘要
|
| | | | S-1 | | |
|
THE OFFERING
|
| | | | S-2 | | |
|
RISK FACTORS
|
| | | | S-4 | | |
|
有關前瞻性陳述的説明
|
| | | | S-7 | | |
|
USE OF PROCEEDS
|
| | | | S-10 | | |
|
DILUTION
|
| | | | S-11 | | |
|
預先出資認股權證説明
|
| | | | S-13 | | |
|
重要的美國聯邦所得税後果
|
| | | | S-15 | | |
|
UNDERWRITING
|
| | | | S-21 | | |
|
LEGAL MATTERS
|
| | | | S-26 | | |
|
EXPERTS
|
| | | | S-26 | | |
|
您可以在哪裏找到更多信息
|
| | | | S-26 | | |
|
通過引用併入某些信息
|
| | | | S-26 | | |
|
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
|
前瞻性信息警示聲明
|
| | | | 2 | | |
|
OUR COMPANY
|
| | | | 4 | | |
|
RISK FACTORS
|
| | | | 5 | | |
|
USE OF PROCEEDS
|
| | | | 6 | | |
|
我們的證券概述
|
| | | | 7 | | |
|
我們的普通股説明
|
| | | | 8 | | |
|
我們的優先股説明
|
| | | | 11 | | |
|
債務證券説明
|
| | | | 14 | | |
|
認股權證説明
|
| | | | 20 | | |
|
DESCRIPTION OF UNITS
|
| | | | 22 | | |
|
證券的合法所有權
|
| | | | 23 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 26 | | |
|
LEGAL MATTERS
|
| | | | 29 | | |
|
EXPERTS
|
| | | | 29 | | |
|
引用合併
|
| | | | 30 | | |
|
您可以在哪裏找到更多信息
|
| | | | 30 | | |
|
本次發行的每股發行價
|
| | | | | | | | | $ | 4.75 | | |
|
截至2022年9月30日的每股有形賬面淨值
|
| | | | 2.20 | | | | | | | | |
|
本年度可歸因於購買者的每股有形賬面淨值增加
offering |
| | | | 0.57 | | | | | | | | |
|
緊接本次發行後的調整後每股有形賬面淨值
|
| | | | | | | | | | 2.77 | | |
|
本次發售中對購買者的每股攤薄
|
| | | | | | | | | $ | 1.98 | | |
Underwriter
|
| |
Number of
Shares |
| |
Number of
Pre-Funded Warrants |
| ||||||
SVB Securities LLC
|
| | | | 4,973,684 | | | | | | 994,737 | | |
RBC資本市場有限責任公司
|
| | | | 4,289,474 | | | | | | 857,895 | | |
坎託·菲茨傑拉德公司
|
| | | | 1,263,158 | | | | | | 252,632 | | |
Total
|
| | | | 10,526,316 | | | | | | 2,105,264 | | |
| | | | | | | | | | | | | | |
Total
|
| |||||||||
| | |
Per
Share |
| |
Per
Pre-Funded Warrant |
| |
Without
Option |
| |
With
Option |
| ||||||||||||
首次公開募股價格
|
| | | $ | 4.750 | | | | | $ | 4.749 | | | | | $ | 59,997,899.74 | | | | | $ | 68,997,900.49 | | |
承保折扣和佣金
|
| | | $ | 0.285 | | | | | $ | 0.285 | | | | | $ | 3,600,000.30 | | | | | $ | 4,140,000.35 | | |
未扣除費用的收益給我們
|
| | | $ | 4.465 | | | | | $ | 4.464 | | | | | $ | 56,397,899.44 | | | | | $ | 64,857,900.14 | | |
Item
|
| |
Page
Number |
| |||
About This Prospectus
|
| | |
|
1
|
| |
前瞻性信息警示聲明
|
| | |
|
2
|
| |
Our Company
|
| | |
|
4
|
| |
Risk Factors
|
| | |
|
5
|
| |
Use of Proceeds
|
| | |
|
6
|
| |
我們的證券概述
|
| | |
|
7
|
| |
我們的普通股説明
|
| | |
|
8
|
| |
我們的優先股説明
|
| | |
|
11
|
| |
債務證券説明
|
| | |
|
14
|
| |
認股權證説明
|
| | |
|
20
|
| |
Description of Units
|
| | |
|
22
|
| |
證券的合法所有權
|
| | |
|
23
|
| |
Plan of Distribution
|
| | |
|
26
|
| |
LEGAL MATTERS
|
| | |
|
29
|
| |
Experts
|
| | |
|
29
|
| |
引用合併
|
| | |
|
30
|
| |
您可以在哪裏找到更多信息
|
| | |
|
30
|
| |